1. Research Framework
1.1. Research Objective
1.2. Product Overview
1.3. Market Segmentation
2. Executive Summary
3. Global Pharmaceutical Glass Packaging Market Insights
3.1. Industry Value Chain Analysis
3.2. DROC Analysis
3.2.1. Growth Drivers
3.2.1.1. Growing pharmaceutical industry driving demand for packaging
3.2.1.2. Superior safety and reliability of glass packaging
3.2.1.3. Increasing market for biologics favoring glass due to compatibility
3.2.2. Restraints
3.2.2.1. Higher cost compared to plastic alternatives
3.2.2.2. Susceptibility to breakage during transportation and handling
3.2.2.3. Environmental sustainability concerns related to energy-intensive production
3.2.3. Opportunities
3.2.3.1. Advancements in lightweight glass formulations and handling technologies
3.2.3.2. Focus on developing recyclable or biodegradable glass materials
3.2.3.3. Expansion opportunities in emerging pharmaceutical markets
3.2.4. Challenges
3.2.4.1. Volatility in raw material prices, such as silica sand
3.2.4.2. Compliance with stringent regulatory requirements
3.2.4.3. Competition from advancing plastic packaging technologies
3.3. Technological Advancements/Recent Developments
3.4. Regulatory Framework
3.5. Porter's Five Forces Analysis
3.5.1. Bargaining Power of Suppliers
3.5.2. Bargaining Power of Buyers
3.5.3. Threat of New Entrants
3.5.4. Threat of Substitutes
3.5.5. Intensity of Rivalry
4. Global Pharmaceutical Glass Packaging Market: Marketing Strategies
5. Global Pharmaceutical Glass Packaging Market Overview
5.1. Market Size & Forecast, 2019-2030
5.1.1. By Value (USD Billion)
5.2. Market Share and Forecast
5.2.1. By Material
5.2.1.1. Type I
5.2.1.2. Type II
5.2.1.3. Type III
5.2.2. By Route of Administration
5.2.2.1. Oral
5.2.2.2. Parenteral
5.2.2.3. Inhalation
5.2.2.4. Others (Topical etc.)
5.2.3. By Product
5.2.3.1. Vials
5.2.3.2. Bottles
5.2.3.3. Cartridges & Syringes
5.2.3.4. Ampoules
5.2.4. By Drug Type
5.2.4.1. Generic
5.2.4.2. Branded
5.2.4.3. Biologics
5.2.5. By Region
5.2.5.1. North America
5.2.5.2. Europe
5.2.5.3. Asia Pacific (APAC)
5.2.5.4. Latin America (LATAM)
5.2.5.5. Middle East and Africa (MEA)
6. North America Pharmaceutical Glass Packaging Market
6.1. Market Size & Forecast, 2019-2030
6.1.1. By Value (USD Billion)
6.2. Market Share & Forecast
6.2.1. By Material
6.2.2. By Route of Administration
6.2.3. By Product
6.2.4. By Drug Type
6.2.5. By Country
6.2.5.1. United States
6.2.5.1.1. By Material
6.2.5.1.2. By Route of Administration
6.2.5.1.3. By Product
6.2.5.1.4. By Drug Type
6.2.5.2. Canada
6.2.5.2.1. By Material
6.2.5.2.2. By Route of Administration
6.2.5.2.3. By Product
6.2.5.2.4. By Drug Type
7. Europe Pharmaceutical Glass Packaging Market
7.1. Market Size & Forecast, 2019-2030
7.1.1. By Value (USD Billion)
7.2. Market Share & Forecast
7.2.1. By Material
7.2.2. By Route of Administration
7.2.3. By Product
7.2.4. By Drug Type
7.2.5. By Country
7.2.5.1. Germany
7.2.5.1.1. By Material
7.2.5.1.2. By Route of Administration
7.2.5.1.3. By Product
7.2.5.1.4. By Drug Type
7.2.5.2. United Kingdom
7.2.5.2.1. By Material
7.2.5.2.2. By Route of Administration
7.2.5.2.3. By Product
7.2.5.2.4. By Drug Type
7.2.5.3. Italy
7.2.5.3.1. By Material
7.2.5.3.2. By Route of Administration
7.2.5.3.3. By Product
7.2.5.3.4. By Drug Type
7.2.5.4. France
7.2.5.4.1. By Material
7.2.5.4.2. By Route of Administration
7.2.5.4.3. By Product
7.2.5.4.4. By Drug Type
7.2.5.5. Spain
7.2.5.5.1. By Material
7.2.5.5.2. By Route of Administration
7.2.5.5.3. By Product
7.2.5.5.4. By Drug Type
7.2.5.6. Belgium
7.2.5.6.1. By Material
7.2.5.6.2. By Route of Administration
7.2.5.6.3. By Product
7.2.5.6.4. By Drug Type
7.2.5.7. Russia
7.2.5.7.1. By Material
7.2.5.7.2. By Route of Administration
7.2.5.7.3. By Product
7.2.5.7.4. By Drug Type
7.2.5.8. The Netherlands
7.2.5.8.1. By Material
7.2.5.8.2. By Route of Administration
7.2.5.8.3. By Product
7.2.5.8.4. By Drug Type
7.2.5.9. Rest of Europe
7.2.5.9.1. By Material
7.2.5.9.2. By Route of Administration
7.2.5.9.3. By Product
7.2.5.9.4. By Drug Type
8. Asia Pacific Pharmaceutical Glass Packaging Market
8.1. Market Size & Forecast, 2019-2030
8.1.1. By Value (USD Billion)
8.2. Market Share & Forecast
8.2.1. By Material
8.2.2. By Route of Administration
8.2.3. By Product
8.2.4. By Drug Type
8.2.5. By Country
8.2.5.1. China
8.2.5.1.1. By Material
8.2.5.1.2. By Route of Administration
8.2.5.1.3. By Product
8.2.5.1.4. By Drug Type
8.2.5.2. India
8.2.5.2.1. By Material
8.2.5.2.2. By Route of Administration
8.2.5.2.3. By Product
8.2.5.2.4. By Drug Type
8.2.5.3. Japan
8.2.5.3.1. By Material
8.2.5.3.2. By Route of Administration
8.2.5.3.3. By Product
8.2.5.3.4. By Drug Type
8.2.5.4. South Korea
8.2.5.4.1. By Material
8.2.5.4.2. By Route of Administration
8.2.5.4.3. By Product
8.2.5.4.4. By Drug Type
8.2.5.5. Australia & New Zealand
8.2.5.5.1. By Material
8.2.5.5.2. By Route of Administration
8.2.5.5.3. By Product
8.2.5.5.4. By Drug Type
8.2.5.6. Indonesia
8.2.5.6.1. By Material
8.2.5.6.2. By Route of Administration
8.2.5.6.3. By Product
8.2.5.6.4. By Drug Type
8.2.5.7. Malaysia
8.2.5.7.1. By Material
8.2.5.7.2. By Route of Administration
8.2.5.7.3. By Product
8.2.5.7.4. By Drug Type
8.2.5.8. Singapore
8.2.5.8.1. By Material
8.2.5.8.2. By Route of Administration
8.2.5.8.3. By Product
8.2.5.8.4. By Drug Type
8.2.5.9. Vietnam
8.2.5.9.1. By Material
8.2.5.9.2. By Route of Administration
8.2.5.9.3. By Product
8.2.5.9.4. By Drug Type
8.2.5.10. Rest of APAC
8.2.5.10.1. By Material
8.2.5.10.2. By Route of Administration
8.2.5.10.3. By Product
8.2.5.10.4. By Drug Type
9. Latin America Pharmaceutical Glass Packaging Market
9.1. Market Size & Forecast, 2019-2030
9.1.1. By Value (USD Billion)
9.2. Market Share & Forecast
9.2.1. By Material
9.2.2. By Route of Administration
9.2.3. By Product
9.2.4. By Drug Type
9.2.5. By Country
9.2.5.1. Brazil
9.2.5.1.1. By Material
9.2.5.1.2. By Route of Administration
9.2.5.1.3. By Product
9.2.5.1.4. By Drug Type
9.2.5.2. Mexico
9.2.5.2.1. By Material
9.2.5.2.2. By Route of Administration
9.2.5.2.3. By Product
9.2.5.2.4. By Drug Type
9.2.5.3. Argentina
9.2.5.3.1. By Material
9.2.5.3.2. By Route of Administration
9.2.5.3.3. By Product
9.2.5.3.4. By Drug Type
9.2.5.4. Peru
9.2.5.4.1. By Material
9.2.5.4.2. By Route of Administration
9.2.5.4.3. By Product
9.2.5.4.4. By Drug Type
9.2.5.5. Rest of LATAM
9.2.5.5.1. By Material
9.2.5.5.2. By Route of Administration
9.2.5.5.3. By Product
9.2.5.5.4. By Drug Type
10. Middle East & Africa Pharmaceutical Glass Packaging Market
10.1. Market Size & Forecast, 2019-2030
10.1.1. By Value (USD Billion)
10.2. Market Share & Forecast
10.2.1. By Material
10.2.2. By Route of Administration
10.2.3. By Product
10.2.4. By Drug Type
10.2.5. By Country
10.2.5.1. Saudi Arabia
10.2.5.1.1. By Material
10.2.5.1.2. By Route of Administration
10.2.5.1.3. By Product
10.2.5.1.4. By Drug Type
10.2.5.2. UAE
10.2.5.2.1. By Material
10.2.5.2.2. By Route of Administration
10.2.5.2.3. By Product
10.2.5.2.4. By Drug Type
10.2.5.3. Qatar
10.2.5.3.1. By Material
10.2.5.3.2. By Route of Administration
10.2.5.3.3. By Product
10.2.5.3.4. By Drug Type
10.2.5.4. Kuwait
10.2.5.4.1. By Material
10.2.5.4.2. By Route of Administration
10.2.5.4.3. By Product
10.2.5.4.4. By Drug Type
10.2.5.5. South Africa
10.2.5.5.1. By Material
10.2.5.5.2. By Route of Administration
10.2.5.5.3. By Product
10.2.5.5.4. By Drug Type
10.2.5.6. Nigeria
10.2.5.6.1. By Material
10.2.5.6.2. By Route of Administration
10.2.5.6.3. By Product
10.2.5.6.4. By Drug Type
10.2.5.7. Algeria
10.2.5.7.1. By Material
10.2.5.7.2. By Route of Administration
10.2.5.7.3. By Product
10.2.5.7.4. By Drug Type
10.2.5.8. Rest of MEA
10.2.5.8.1. By Material
10.2.5.8.2. By Route of Administration
10.2.5.8.3. By Product
10.2.5.8.4. By Drug Type
11. Competitive Landscape
11.1. List of Key Players and Their Offerings
11.2. Global Pharmaceutical Glass Packaging Market Share Analysis, 2023
11.3. Competitive Benchmarking, By Operating Parameters
11.4. Key Strategic Developments (Mergers, Acquisitions, Partnerships, etc.)
12. Impact of Escalating Geopolitical Tensions on Global Pharmaceutical Glass Packaging Market
13. Company Profiles (Company Overview, Financial Matrix, Competitive Landscape, Key Personnel, Key Competitors, Contact Address, Strategic Outlook, and SWOT Analysis)
13.1. Corning Incorporated
13.2. Nipro Corporation
13.3. Shandong Medicinal Glass Co., Ltd
13.4. Bormioli Pharma S.p.A.
13.5. Owens-Illinois, Inc.
13.6. SGD S.A.
13.7. Stoelzle Oberglas GmbH
13.8. Gerresheimer AG
13.9. West Pharmaceutical Services, Inc.
13.10. Piramal Enterprises Ltd
13.11. Arab Pharmaceutical Glass Co.
13.12. Ardagh Group S.A.
13.13. ?i?ecam Group
13.14. Beatson Clark
13.15. DWK Life sciences
13.16. Other Prominent Players
14. Key Strategic Recommendations
15. Research Methodology
15.1. Qualitative Research
15.1.1. Primary & Secondary Research
15.2. Quantitative Research
15.3. Market Breakdown & Data Triangulation
15.3.1. Secondary Research
15.3.2. Primary Research
15.4. Breakdown of Primary Research Respondents, By Region
15.5. Assumptions & Limitations
*Financial information of non-listed companies can be provided as per availability.
**The segmentation and the companies are subject to modifications based on in-depth secondary research for the final deliverable